THERAPEUTIC IMPLICATIONS OF BIOAVAILABILITY

被引：8
作者：
AZARNOFF, DL
HUFFMAN, DH
机构：
[1] UNIV KANSAS,MED CTR,DEPT MED,KANSAS CITY,KS 66103
[2] UNIV KANSAS,MED CTR,DEPT PHARMACOL,KANSAS CITY,KS 66103
[3] VET ADM HOSP,KANSAS CITY,MO 64128
来源：
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY | 1976年 / 16卷
关键词：
D O I：
10.1146/annurev.pa.16.040176.000413
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：53 / 66
页数：14
相关论文
共 128 条
[41]   COMPARISON OF BLOOD LEVELS OBTAINED AFTER SINGLE + MULTIPLE DOSES OF ERYTHROMYCIN ESTOLATE + ERYTHROMYCIN STEARATE [J].
GRIFFITH, RS ;
BLACK, HR .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1964, 247 (01) :69-&
[42]   ABSORPTION CHARACTERISTICS OF PARACETAMOL TABLETS IN MAN [J].
GWILT, JR ;
GOLDMAN, L ;
BLANCHARD, AW ;
ROBERTSON, A .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1963, 15 (07) :445-+
[43]  
HAILEY FJ, 1967, CURR THER RES CLIN E, V9, P600
[44]  
HALLIDAY A, 1961, ANTIMICROB AGENTS CH, P317
[45]  
HARRIS W, 1961, T VA AF CHEMOTHER C, V20, P39
[46]   PROTECTION OF POLYNUCLEOTIDE PHOSPHORYLASE BY SUBSTRATES AGAINST UREA INACTIVATION [J].
HARVEY, RA ;
GODEFROY, T ;
LUCASLEN.J ;
GRUNBERG.M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1967, 1 (03) :327-&
[47]   ABSORPTION OF DIGOXIN IN PATIENTS WITH MALABSORPTION SYNDROMES [J].
HEIZER, WD ;
SMITH, TW ;
GOLDFINGER, SE .
NEW ENGLAND JOURNAL OF MEDICINE, 1971, 285 (05) :257-+
[48]   CHLOROMYCETIN (CHLORAMPHENICOL) IN THE TREATMENT OF INFECTIONS [J].
HEWITT, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 1950, 242 (04) :119-127
[49]   COMPARATIVE ACTIVITY OF 4 TETRACYCLINE ANALOGUES AGAINST PATHOGENIC BACTERIA INVITRO [J].
HIRSCH, HA ;
FINLAND, M .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1960, 239 (03) :288-294
[50]  
HIRSCH HA, 1959, AM J MED SCI, V237, P55
12345678910